GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,449.00GBp
19 Sep 2014
Price Change (% chg)

12.50p (+0.87%)
Prev Close
1,436.50p
Open
1,449.50p
Day's High
1,456.00p
Day's Low
1,433.00p
Volume
19,191,745
Avg. Vol
8,285,611
52-wk High
1,709.00p
52-wk Low
1,365.00p

GSK.L

Chart for GSK.L

About

GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK’s principal pharmaceutical products include medicines in... (more)

Overall

Beta: 0.49
Market Cap (Mil.): £70,271.27
Shares Outstanding (Mil.): 4,849.64
Dividend: 19.00
Yield (%): 5.52

Financials

  GSK.L Industry Sector
P/E (TTM): 14.91 32.84 33.70
EPS (TTM): 0.97 -- --
ROI: 18.08 18.11 17.35
ROE: 75.85 18.82 18.21
Search Stocks

China hands drugmaker GSK record $489 million fine for paying bribes

SHANGHAI/LONDON - China fined GlaxoSmithKline Plc a record 3 billion yuan ($489 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the British drugmaker.

19 Sep 2014

UPDATE 4-China hands drugmaker GSK record $489 mln fine for paying bribes

* Former China head gets suspended sentence, to be deported

19 Sep 2014

BUSINESS-NEWS-SCHEDULE AT 1230 GMT / 8.30 AM ET

Editor: Malcolm Davidson +44 20 7542 6958

19 Sep 2014

GSK ex-China head Mark Reilly to be deported from China, won't face jail time: source

SHANGHAI - Mark Reilly, the former China head of British drugmaker GlaxoSmithKline PLC , will be deported from China and will not face jail time in the country, according to a source with direct knowledge of the matter.

19 Sep 2014

GSK ex-China head Mark Reilly to be deported from China, won't face jail time - source

SHANGHAI, Sept 19 - Mark Reilly, the former China head of British drugmaker GlaxoSmithKline PLC, will be deported from China and will not face jail time in the country, according to a source with direct knowledge of the matter.

19 Sep 2014

China fines GSK $489 mln, jails executives -Xinhua

BEIJING, Sept 19 - China has fined British pharmaceuticals giant GlaxoSmithKline Plc 3 billion yuan ($488.8 million) for paying out bribes in what is a record penalty for China, state news agency Xinhua said on Friday.

19 Sep 2014

BRIEF-GSK says Chinese court finds unit guilty of bribing non-government personnel

* Changsha intermediate People's Court in Hunan Province, China ruled that GSK China Investment Co. Ltd (GSKCI) has, according to Chinese law, offered money or property to non-government personnel

19 Sep 2014

GSK melanoma pill backed by UK cost watchdog with price cut

LONDON - Britain's healthcare cost agency NICE has recommended a third new drug for melanoma, this time from GlaxoSmithKline, after the drugmaker offered to supply it at a discount to the state-run National Health Service.

17 Sep 2014

GSK melanoma pill backed by UK cost watchdog with price cut

LONDON, Sept 18 - Britain's healthcare cost agency NICE has recommended a third new drug for melanoma, this time from GlaxoSmithKline, after the drugmaker offered to supply it at a discount to the state-run National Health Service.

17 Sep 2014

UPDATE 1-First UK volunteer gets experimental GSK Ebola shot in trial

LONDON, Sept 17 - The first volunteer in a fast-tracked British safety trial of an experimental Ebola vaccine made by GlaxoSmithKline received the injection on Wednesday, trial organisers said.

17 Sep 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks